205 related articles for article (PubMed ID: 23714504)
1. Individualizing treatment decisions for older adults with hematologic malignancies.
Klepin HD; Rizzieri D; Palumbo A; Magarotto V; Eichhorst B
Am Soc Clin Oncol Educ Book; 2013; ():208-19. PubMed ID: 23714504
[TBL] [Abstract][Full Text] [Related]
2. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Huang LW; Wong SW; Andreadis C; Olin RL
Curr Oncol Rep; 2019 Mar; 21(4):35. PubMed ID: 30848394
[TBL] [Abstract][Full Text] [Related]
3. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
Olin RL
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):63-70. PubMed ID: 31808886
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive approach to therapy of haematological malignancies in older patients.
Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
[TBL] [Abstract][Full Text] [Related]
6. Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper.
Loh KP; Christofyllakis K; Huang LW; Mims A
J Geriatr Oncol; 2019 Mar; 10(2):186-191. PubMed ID: 30661875
[No Abstract] [Full Text] [Related]
7. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
McSweeney PA; Niederwieser D; Shizuru JA; Sandmaier BM; Molina AJ; Maloney DG; Chauncey TR; Gooley TA; Hegenbart U; Nash RA; Radich J; Wagner JL; Minor S; Appelbaum FR; Bensinger WI; Bryant E; Flowers ME; Georges GE; Grumet FC; Kiem HP; Torok-Storb B; Yu C; Blume KG; Storb RF
Blood; 2001 Jun; 97(11):3390-400. PubMed ID: 11369628
[TBL] [Abstract][Full Text] [Related]
8. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
Olin RL
Blood; 2019 Dec; 134(23):2013-2021. PubMed ID: 31805199
[TBL] [Abstract][Full Text] [Related]
9. Personalizing therapy for older adults with lymphoid malignancies: options and obstacles.
Wildes TM; Goede V; Hamlin P
Am Soc Clin Oncol Educ Book; 2014; ():e240-8. PubMed ID: 24857108
[TBL] [Abstract][Full Text] [Related]
10. Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment.
Hemminki K; Hemminki J; Försti A; Sud A
Leukemia; 2023 Apr; 37(4):854-863. PubMed ID: 36828868
[TBL] [Abstract][Full Text] [Related]
11. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
12. Management of older adults with myelodysplastic syndromes (MDS).
Luskin MR; Abel GA
J Geriatr Oncol; 2018 Jul; 9(4):302-307. PubMed ID: 29290596
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia.
DeFilipp Z; Huynh DV; Fazal S; Sahovic E
Hematol Oncol Stem Cell Ther; 2012; 5(3):165-8. PubMed ID: 23095794
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
Klepin HD
Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
[TBL] [Abstract][Full Text] [Related]
15. Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies.
Garric M; Sourdet S; Cabarrou B; Steinmeyer Z; Gauthier M; Ysebaert L; Beyne-Rauzy O; Gerard S; Lozano S; Brechemier D; Filleron T; Mourey L; Balardy L
Eur J Haematol; 2021 May; 106(5):616-626. PubMed ID: 33340150
[TBL] [Abstract][Full Text] [Related]
16. Clinical research in older adults with hematologic malignancies: Opportunities for alignment in the Veterans Affairs.
Graf SA; Samples LS; Keating TM; Garcia JM
Semin Oncol; 2019; 46(4-5):341-345. PubMed ID: 31606147
[TBL] [Abstract][Full Text] [Related]
17. [Hematology 2009].
Dreyling M; Spiekermann K; Hiddemann W
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1367-9. PubMed ID: 19517333
[No Abstract] [Full Text] [Related]
18. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
19. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
20. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.
Kusnierz-Glaz CR; Schlegel PG; Wong RM; Schriber JR; Chao NJ; Amylon MD; Hu WW; Negrin RS; Lee Y; Blume KG; Long GD
J Clin Oncol; 1997 Jan; 15(1):18-25. PubMed ID: 8996120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]